PMID- 22737243 OWN - NLM STAT- MEDLINE DCOM- 20121214 LR - 20211021 IS - 1932-6203 (Electronic) IS - 1932-6203 (Linking) VI - 7 IP - 6 DP - 2012 TI - Electrical stimulation to conductive scaffold promotes axonal regeneration and remyelination in a rat model of large nerve defect. PG - e39526 LID - 10.1371/journal.pone.0039526 [doi] LID - e39526 AB - BACKGROUND: Electrical stimulation (ES) has been shown to promote nerve regeneration when it was applied to the proximal nerve stump. However, the possible beneficial effect of establishing a local electrical environment between a large nerve defect on nerve regeneration has not been reported in previous studies. The present study attempted to establish a local electrical environment between a large nerve defect, and examined its effect on nerve regeneration and functional recovery. METHODOLOGY/FINDINGS: In the present study, a conductive scaffold was constructed and used to bridge a 15 mm sciatic nerve defect in rats, and intermittent ES (3 V, 20 Hz) was applied to the conductive scaffold to establish an electrical environment at the site of nerve defect. Nerve regeneration and functional recovery were examined after nerve injury repair and ES. We found that axonal regeneration and remyelination of the regenerated axons were significantly enhanced by ES which was applied to conductive scaffold. In addition, both motor and sensory functional recovery was significantly improved and muscle atrophy was partially reversed by ES localized at the conductive scaffold. Further investigations showed that the expression of S-100, BDNF (brain-derived neurotrophic factor), P0 and Par-3 was significantly up-regulated by ES at the conductive scaffold. CONCLUSIONS/SIGNIFICANCE: Establishing an electrical environment with ES localized at the conductive scaffold is capable of accelerating nerve regeneration and promoting functional recovery in a 15 mm nerve defect in rats. The findings provide new directions for exploring regenerative approaches to achieve better functional recovery in the treatment of large nerve defect. FAU - Huang, Jinghui AU - Huang J AD - Institute of Orthopaedics, Xijing Hospital, The Fourth Military Medical University, Xi'an, China. FAU - Lu, Lei AU - Lu L FAU - Zhang, Jianbin AU - Zhang J FAU - Hu, Xueyu AU - Hu X FAU - Zhang, Yongguang AU - Zhang Y FAU - Liang, Wei AU - Liang W FAU - Wu, Siyu AU - Wu S FAU - Luo, Zhuojing AU - Luo Z LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20120621 PL - United States TA - PLoS One JT - PloS one JID - 101285081 RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (Carrier Proteins) RN - 0 (Myelin P0 Protein) RN - 0 (Nerve Tissue Proteins) RN - 0 (Pard3 protein, rat) RN - 0 (S100 Proteins) RN - 9012-76-4 (Chitosan) SB - IM MH - Action Potentials MH - Animals MH - Axons/pathology/*physiology MH - Brain-Derived Neurotrophic Factor/biosynthesis MH - Carrier Proteins/biosynthesis MH - Chitosan/chemistry MH - Disease Models, Animal MH - *Electric Stimulation MH - Electrophysiology/methods MH - Male MH - Myelin P0 Protein/biosynthesis MH - Myelin Sheath/*metabolism MH - Nerve Regeneration/*physiology MH - Nerve Tissue Proteins MH - Neurons/metabolism MH - Rats MH - Rats, Sprague-Dawley MH - S100 Proteins/biosynthesis MH - Sciatic Nerve/pathology MH - Up-Regulation PMC - PMC3380893 COIS- Competing Interests: The authors have declared that no competing interests exist. EDAT- 2012/06/28 06:00 MHDA- 2012/12/15 06:00 PMCR- 2012/06/21 CRDT- 2012/06/28 06:00 PHST- 2011/10/03 00:00 [received] PHST- 2012/05/23 00:00 [accepted] PHST- 2012/06/28 06:00 [entrez] PHST- 2012/06/28 06:00 [pubmed] PHST- 2012/12/15 06:00 [medline] PHST- 2012/06/21 00:00 [pmc-release] AID - PONE-D-11-19433 [pii] AID - 10.1371/journal.pone.0039526 [doi] PST - ppublish SO - PLoS One. 2012;7(6):e39526. doi: 10.1371/journal.pone.0039526. Epub 2012 Jun 21.